Understanding the mechanisms regulating expression of retinal ganglion cell (RGC) specific and axonguidance genes during development and in retinal stem cells will be critical for successful optic nerve regeneration. Müller glia have some characteristics of retinal stem cells but in mammals have demonstrated limited potential to differentiate into RGCs. Chromatin remodeling through histone deacetylation and DNA methylation are a potential mechanism for silencing genes necessary for neuronal differentiation of glial cells. We investigated DNA methylation as a mechanism for regulating expression of mouse EphA5, one member of a large family of ephrin receptor genes that regulate patterning of the topographic connections of RGCs during visual system development. We analyzed spatial and age-related patterns of EphA5 promoter methylation by bisulfite sequencing and mRNA expression by quantitative RT-PCR in the mouse retina. The CpG island in the EphA5 promoter was hypomethylated in the retina and showed no change in overall methylation with age, despite a decline in EphA5 mRNA expression levels in the adult retina. In the nasal retina of post-natal day 0 mice, there was a modest, but statistically significant increase in methylation. Increased methylation corresponded with lower levels of receptor mRNA expression in the nasal retina. We cloned the EphA5 promoter and found that site-specific differences in methylation could preferentially activate or repress promoter activity in transient transfections of rat retinal progenitor cells (R28) using luciferase assays. In sphere cultures generated by EGF/FGF2 stimulation of conditionally immortalized mouse Müller glia (ImM10), EphA5 promoter was hypermethylated and EphA5 mRNA was not detected. Demethylation using 5-azadeoxycytidine (AzadC) resulted in a significant decrease of methylation of the EphA5 promoter and re-expression of the EphA5 mRNA. The inverse relationship between EphA5 promoter methylation and mRNA expression is consistent with a role for DNA methylation in modulating the spatial patterns of EphA5 gene expression in the retina and in silencing EphA5 expression in ImM10 cells. The robust up-regulation of EphA5 in ImM10 cells following demethylation suggests that modulation of chromatin structure may be a useful approach for promoting expression of silenced developmental genes and increasing the neurogenic potential of Müller glia.
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Introduction
Currently there are no cures for neurodegenerative diseases that affect the optic nerve. Even if progression can be stopped, there is a need to develop regenerative therapies to restore lost vision. In mammals, the retina and optic nerve do not regenerate. However, in teleost fish, Müller glia are the source of the retinal stem cells in the inner retina that generate rod photoreceptors during normal growth and can regenerate all classes of retinal neurons including RGCs following injury (Bernardos, Barthel, Meyers, & Raymond, 2007; Otteson, D'Costa, & Hitchcock, 2001) . The robust neurogenic capacity of Müller glia in fish and, to a more limited extent, in birds (Fischer & Reh, 2003) has stimulated research to understand the stem cell properties and neurogenic potential of Müller glia in the mammalian retina both in vivo and in vitro (Bhatia, Singhal, Lawrence, Khaw, & Limb, 2009; Dyer & Cepko, 2000; Karl et al., 2008; Ooto et al., 2004; Wohl, Schmeer, Kretz, Witte, & Isenmann, 2009) . The challenges for developing cell-replacement strategies to treat optic neuropathies will require not only identifying how to regenerate retinal ganglion cells (RGCs), but also how to promote 0042-6989/$ -see front matter Ó 2010 Elsevier Ltd. All rights reserved. doi:10.1016/j.visres.2010.09.022
Abbreviations: qRT-PCR, quantitative real time reverse transcriptase PCR; CpG, cytosine-guanine dinucleotide; Ct, crossing threshold; RGC, retinal ganglion cell; gDNA, genomic DNA; AzadC, 5-azadeoxycytidine; LB, Luria broth; MTT, methylthiazolyldiphenyl-tetrazolium bromide; TSS, transcription start site; ImM10, Immortomouse Müller glia P10 cell line. axon growth and connectivity. For functional vision, the spatial relationship between neighboring retinal ganglion cells (RGC) in the retina must be preserved in the topographic organization of their synaptic connections in the visual centers of the brain. In the visual system, forward and reverse signaling through Ephrin receptors (Eph) and ephrin ligands functions as chemoaffinity signals that regulate retinotopic mapping.
Eph receptors constitute a family of tyrosine kinase receptors that regulate multiple aspects of development and disease including vascular development (Zhang & Hughes, 2006) and synaptogenesis (Murai & Pasquale, 2004; Otal, Burgaya, Frisen, Soriano, & Martinez, 2006) . More recently, disregulation of EPH/ephrin signaling has also been implicated in oncogenesis and tumor progression (Merlos-Suarez & Batlle, 2008) . However, one of their most well known functions is in patterning the formation of sensory maps in the central nervous system during development (Scicolone, Ortalli, & Carri, 2009 ). In the visual system, gradients of Eph receptors along the nasal/temporal and dorsal/ventral axes of the retina respond to corresponding gradients of ephrin ligands in target regions within the brain to create the positional information that guides the initial spatial organization of RGC connectivity (Feldheim et al., 2004; Flanagan, 2006; Scicolone et al., 2009 ). In the mouse retina, EphA5 is expressed in an increasing nasal to temporal gradient and functions in patterning the location of retinal axon termination along the anterior-posterior axis in the visual centers in the brain. In the mouse retina, EphA5 expression is initiated during the optic vesicle stage. By E11, when the first retinal ganglion cells begin to differentiate, EphA5 expression in the neuroblastic layer and nascent RGCs extends in a temporal (high) to nasal (low) gradient across the optic cup (Cooper, Crockett, Nowakowski, Gale, & Zhou, 2009 ). Axon outgrowth begins at E12 and by E17, RGCs have projected through the optic tract and have begun to reach targets and arborize in the ventral lateral geniculate nucleus and superior colliculus (Bovolenta & Mason, 1987; Godement, Salaun, & Imbert, 1984) . Graded EphA5 expression is prominent in the inner retina and RGC layer beginning at E12, and by E17.5, when all RGCs have been generated, the gradient of EphA5 is robust in the RGC layer (Cooper et al., 2009) . By P0, the retinal ganglion cells fibers have established their terminal connections, but have not yet entered the subsequent period of connection refinement. Although the gradient of EphA5 expression persists in the ganglion cell layer in the adult retina, there is a gradual decline in overall expression and a flattening of the gradient with age (Rodger et al., 2001) . Loss of EphA5 receptor leads to mapping abnormalities along the anterior/posterior axis of the mouse superior colliculus (Feldheim et al., 2004) confirming the importance of the receptor in the positional termination of retinal axons.
While there is extensive literature showing direct regulation of EphB receptors by transcription factors (reviewed by (Petros, Rebsam, & Mason, 2008) , little is known about transcriptional mechanisms regulating EphA5 expression in the retina. Hmx family transcription factors, SOHO and GH6, have been implicated in regulation of EphA3 expression in chick (Schulte & Cepko, 2000) and, in the developing mouse retina, Hmx1 is expressed in a nasal high/temporal low gradient (Wang, Lo, Frasch, & Lufkin, 2000) . However, the role of Hmx1 in regulating EphA5 expression in the mouse retina has not been determined. FoxD1 and FoxG1 are expressed in reciprocal gradients in the developing mouse retina (Hatini, Tao, & Lai, 1994) and regulate formation of the contralateral and ipsilateral pathways and optic chiasm in the mouse (Herrera et al., 2004; Pratt, Tian, Simpson, Mason, & Price, 2004; Tian, Pratt, & Price, 2008) . However, only EphB1 has been proposed as a downstream target of FOX transcription factors in the mouse retina and the specific transcription factors that regulate EphA5 expression in the retina have not been determined.
DNA methylation is an epigenetic mechanism for regulating gene transcription in embryonic stem cells during differentiation and development (Yeo et al., 2007) and increased DNA methylation of CpG islands is associated with gene silencing (Bird, 2002) . Except in oocytes and cancer, hypermethylation has typically been thought of as an irreversible chromatin modification. However, several studies have shown that demethylation of cell-type specific genes is dynamic (Frank et al., 1990; Meissner et al., 2008; Song et al., 2009) . During development, 2% of the CpG islands that are methylated in embryonic stem cells become demethylated in neural progenitors (Meissner et al., 2008) . All of the Eph receptor genes contain CpG islands within their proximal promoters and hypoand hypermethylation can alter Eph receptor expression in cancer. Hypermethylation down-regulates EphA3 in hematopoietic tumors (Dottori, Down, Huttmann, Fitzpatrick, & Boyd, 1999) and EphA7 in colon cancer (Wang et al., 2005) and increased methylation of EphA5 is correlated with decreased expression in primary breast cancer (Fu et al.) . Conditional knockout of Dnmt1, the maintenance DNA methyltransferase, in mouse neural progenitors resulted in increased differentiation of astroglia in the mouse brain, indicating a role for DNA methylation in the switch from neurogenesis to gliogenesis.
Recent transcriptome analysis has revealed that Müller glia express many, but not all of the same genes expressed by undifferentiated retinal progenitor cells in the embryonic retina (Roesch et al., 2008) . In the mature retina in mammals, some Müller glia proliferate in the context of retinal injury or disease in vivo and a fraction up-regulate genes characteristic of differentiated retinal neurons (Dyer & Cepko, 2000; Karl et al., 2008; Wohl, Schmeer, Kretz, Witte, & Isenmann, 2009) . Cultured Müller glia from human (Lawrence et al., 2007) , rat (Kubota, Nishida, Nakashima, & Tano, 2006) and mouse (Das et al., 2006; Otteson & Phillips, 2010; Phillips, Guirguis, Beach, Pillai, & Otteson, 2008) show stem cell characteristics, including expression of multiple retinal stem cell genes and formation of proliferating neurospheres in response to epidermal growth factor (EGF) and fibroblast growth factor 2 (FGF2). However, Müller-derived cells are quite limited in their neurogenic potential both in vivo and in vitro, and only a fraction acquire neuronal characteristics or up-regulate genes characteristic of differentiated retinal neurons. Single cell microarray analysis of gene expression showed that many key genes that regulate retinal ganglion cell development and differentiation, including Atoh7, Pou4F2, Isl2 and EphA5, were either not expressed or expressed at low levels only in a subset of Müller glia cells examined (Roesch et al., 2008) .
Understanding the mechanisms that regulate expression of key genes involved in RGC developmental and axon guidance in the retina and in Müller glia will contribute to the development of regenerative therapies to restore the optic nerve and vision in patients with glaucoma. We describe here the cloning of the mouse EphA5 promoter and address the potential role of DNA methylation in regulating EphA5 expression in the mouse retina in vivo and in conditionally immortalized Müller glia (ImM10 cell line) in vitro.
Materials and methods

Cell culture
The following cell lines were used: the R28 rat retinal progenitor cell line (Seigel, 1996) and the ImM10 conditionally immortalized Müller glia cell line (Otteson & Phillips, 2010) . R28 cells were cultured in DMEM (Sigma; St. Louis, MO) supplemented with 1.125% sodium bicarbonate, 10% calf serum, 1% each MEM nonessential amino acids and MEM vitamins, 2 mM L-glutamine and 0.1 mg/ml gentamicin. ImM10 cells were cultured in growth medium (Neurobasal, 2% FBS, B27 supplement, 20 mM L-glutamine, 50 U/ml IFNc, Pen/strep antibiotics) at 33°C. To generate spheres, cells were cultured under non-immortalizing conditions to eliminate expression of the temperature-sensitive inducible SV40 large T-antigen in serum free Neurobasal medium, supplemented with B27, G5 and 20 mM L-glutamine with final concentrations of EGF and FGF2 at 20 ng/ml and cultured at 39°C for 5 days (Fig. 5 ). Unless otherwise specified, cell culture reagents and supplements were from Gibco/Invitrogen (Carlesbad, CA) and growth factors/ cytokines (EGF, FGF2 and IFNc) were from PeproTech (Rock Hill, NJ).
Animals and retinal dissection
All animals were handled in accordance with the Animal Care Policies of the University of Houston and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Mice were maintained in a 12-h dark/12-h light cycle with food and water ad libitum. Adult animals were euthanized by halothane inhalation, followed by cervical dislocation; P0 animals were euthanized by hypothermia followed by decapitation. For collection of embryonic day 17.5 (E17.5) retinas, mice were mated overnight; the presence of vaginal plug was marked as E0.5. For P0 eyes used for isolating nasal/temporal and dorsal/ventral retinal samples, the ocular orientation was marked with ink prior to enucleation. Following enucleation, eyes were rinsed twice in 70% ethanol, followed by two rinses in sterile PBS prior to removal of the anterior segment. The eyecup was placed in pre-warmed CO 2 independent medium and the anterior chamber was removed. For isolation of whole retina (E17.5, P0 and 8 months), the retina dissected free of the pigmented epithelium. For analysis of spatial expression and DNA methylation, the eyecup was cut into thirds on either side of the optic nerve head and retina dissected free of the pigmented epithelium. To obtain the nasal and temporal retinal samples, the cuts were along dorsal/ventral axis. To obtain the dorsal and ventral retinal samples, the cuts were along the nasal/temporal axis.
Genomic DNA and RNA isolation
Total RNA and gDNA from retinal tissues and ImM10 cells were isolated using AllPrep DNA/RNA columns (Qiagen; Valencia, CA). Cells were lysed in a guanidine hydrochloride buffer, homogenized through a 20-gauge needle and loaded onto affinity columns that retain genomic DNA, but not RNA. The flow through from the first column containing total RNA was purified using RNeasy mini spin columns (Qiagen; Valencia, CA), eluted in RNAse free buffer and stored at À80°C. Genomic DNA retained in the first column was washed and eluted in Tris buffer and stored at À20°C. Nucleic acids were quantified by spectrophotometry (Nanodrop; ThermoScientific, Wilmington, DE) and RNA quality was assessed using an RNA 6000 NanoChip on a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA).
Cloning and in vitro methylation of EphA5 promoter
The EphA5 promoter region from À1552 to +997 bp relative to the transcription start site was PCR amplified from mouse genomic DNA using Pfx Taq polymerase (Invitrogen, Carlsbad, CA). Primers used are listed in Supplementary Table S1 . The amplicon was subcloned into pCR2.1-topo (Invitrogen) and sequence verified. For subcloning into pGL2 basic, the insert was isolated by digestion with NotI, overhangs were filled in using DNA polymerase, Klenow fragment and re-digested with Acc65I. Following gel purification, the insert was directionally cloned into pGL2-basic that had been linearized with BglII, filled in with Klenow and re-digested with Acc65I. For subcloning into the CpG-free, pCpGL-basic luciferase vector (Klug & Rehli, 2006) , the insert was excised from the pGL2 plasmid using Acc65I/BamHI and directionally cloned into Acc65I/BamHI digested pCpGL-basic.
For methylation analysis, plasmid DNA (4 lg) was methylated with SssI, HhaI, and/or HpaII methyltransferase enzymes (3 U/lg DNA, Promega; San Luis Obispo, CA) in the presence of 160 lM S-adenosylmethionine (SAM) for 4 h at 37°C. Mock methylated DNA was treated as above, without addition of the methyltransferase enzyme. DNA was ethanol precipitated and completeness of methylation was verified by restriction enzyme digestion using methylation sensitive HhaI, HpaII and BstUI and methylation insensitive MspI.
Luciferase assays
For luciferase assays experiments, R28 cells were seeded at 160,000 cells/well in a 24-well plate and incubated for 24 h. Cells were then transfected with 0.1, 0.25 or 0.5 lg luciferase reporter vector and 20 ng Renilla-luciferase control vector using Lipofectamine LTX reagent (Invitrogen; Carlsbad, CA). After 48 h incubation, cells were lysed in passive lysis buffer and lysates were assayed for firefly and pRL-Renilla luciferase activity using DualLuciferase Reporter System (Promega; San Luis Obispo, CA) on a 20/20n Luminometer (Promega Corp., Sunnyvale, CA). Firefly luciferase activity of individual samples was normalized to Renilla luciferase activity to correct for variation in transfection efficiency between samples. Each condition was tested in triplicate and the entire experiment was repeated three times.
Quantitative RT-PCR
For each sample, RNA was assayed by quantitative RT-PCR (qRT-PCR) to determine expression levels of EphA5 mRNA using gene specific primers (Supplementary Table S1 ). For mRNA analysis, 500 ng of total RNA were reverse transcribed using Affinity Script Reverse Transcription kit (Stratagene; La Jolla, CA). cDNA was diluted 1:20 and processed in triplicate reactions for qRT-PCR using SYBR Green QRT-PCR 2 step kit (Stratagene; La Jolla, CA) on a Stratagene MX3500 real-time PCR instrument. Ct values were normalized to housekeeping gene (Rplp0, acidic ribosomal phosphoprotein P0) (Simpson, Feeney, Boyle, & Stitt, 2000) . To compare mRNA expression between the experimental groups, relative quantities were calculated using the DDCt-method using Relative Expression Software Tool (REST, http://www.gene-quantification.de) (Pfaffl, Horgan, & Dempfle, 2002) . For qRT-PCR analysis, three biological replicates were analyzed for each sample.
Bisulfite sequencing
Mouse genomic DNA (gDNA) was bisulfite converted using DNA EZmethylation Gold kit (Zymo Research; Orange, CA) according to manufacturer's recommendations. Briefly, 500 ng of gDNA were treated with CT conversion reagent at 98°C for 10 min and 64°C for 2.5 h, followed by purification and desulphonation. gDNA was eluted with 10 ll of M-elution buffer, quantified by spectrophotometry (NanoDrop, ThermoScientific, Wilmington, DE) and stored at À80°C. PCR primers were designed for bisulfite converted DNA using Methprimer (http://www.urogene.org/methprimer/index1. html) (Li & Dahiya, 2002) for EphA5, EphB2 and H19 (Supplementary  Table S1 ). Primer specificity for bisulfite converted DNA was verified by PCR amplification of methylated and unmethylated, bisulfite converted plasmid DNA. Target sequences were amplified with two rounds of hot start PCR reaction using nested primers with Red Taq Genomic DNA Polymerase (Sigma; St. Louis, MO). The following cycling conditions were used: 2 min at 94°C, 35 cycles (30 s at 94°C, 30 s at 52°C, 2 min at 68°C), 5 min at 68°C. Amplicons were purified using PCR affinity columns (QIAquick PCR purification kit; Qiagen; Valencia, CA), subcloned into pCR2.1 (Invitrogen; Carlsbad, CA), transformed into E. coli (DH5-alpha) and grown on LB agar plates containing kanamycin with X-gal/ IPTG blue/white selection. For each condition, at least 10 isolated colonies were picked and sequenced (Macrogen USA, MD). Sequences were compiled and compared using Quantification tool for Methylation Analysis QUMA (http://quma.cdb.riken.jp/) (Kumaki, Oda, & Okano, 2008) . Clones with less than 95% C to T conversion of non-CpG cytosine residues were excluded from analysis based on incomplete bisulfite conversion. For methylation analysis of retinal samples, two biological replicates were analyzed. For methylation analysis of ImM10 cells, one biological sample was analyzed for each condition.
MMT assays for AzadC cytotoxicity
Cytotoxic assay was performed to determine the concentration of AzadC that leads to demethylation with minimum cell death. ImM10 cells were seeded at 7500 cells/well onto 96 well plates in sphere forming medium and incubated overnight at 39°C. Quadruplicate wells were treated with 0, 1, 2, 5, 10, 20, 50, 100, or 500 lM final concentration of 5-aza-2-dioxicytidine (AzadC, Sigma, St. Louis, MO), with daily 100% media changes to insure the presence of active AzadC. After a total incubation time of 72 h, Methylthiazolyldiphenyl-tetrazolium bromide (MTT) reagent was added (20 ll at 5 mg/ml), incubated for 3.5 h at 39°C. The media was removed and reactions were terminated by addition of 150 ll of stopping solution (4 mM HCl in isopropanol) and formazan crystals were dissolved by pipetting. Absorbance was measured at 590 nm with reference filter 635 nm using (FLUOstar Omega, BMG Labtech) and the adjusted optical density value (OD at 590 nm minus OD at 635 nm) was plotted vs. concentration of AzadC ( Supplementary Fig. S1 ).
AzadC assays of ImM10 cells
ImM10 cells were grown to confluence in growth medium in 100 mm culture plates, harvested by trypsinization and split 1:3 into 100 mm culture plates in sphere forming media under nonimmortalizing conditions and incubated overnight at 39°C (Section 2.1 for culture media). Cells were treated with AzadC (1 or 10 lM final concentration) or vehicle (PBS) for 72 h, with daily 100% media changes to insure the activity of the AzadC. At 72 h, cells were harvested for combined genomic DNA and RNA extraction and analysis.
Results
Cloning and sequence analysis of EphA5 promoter
The mouse EphA5 gene is located on chromosome 5qE1 in a region of synteny with human chromosome 4 and, like the human gene, contains two CpG islands (Fig. 1) . The first spans the transcription start site [À327 to +387 relative to the transcription start site (TSS)] and contains 65.1% GC with an observed to expected CpG ratio of 0.839. The second is in the coding region of EphA5 exon 1 and extends into intron 1 (+557 to +1348 relative to the TSS) with a CG content >58.5% and an observed to expected ratio of CpG dinucleotides of 0.622. We have cloned the mouse EphA5 promoter from À1556 to +997 base pairs relative to the transcription start site, from mouse genomic DNA. This region includes a proximal conserved region surrounding the transcription start site and a distal conserved region located between À1200 and À1500 bp. We tested the EphA5 promoter activity in mouse R28 rat retinal progenitor cells using luciferase assays. The mouse EphA5 promoter was active in R28 cells (Fig. 2) , consistent with RT-PCR analysis that showed that R28 cells expressed EphA5 (data not shown).
EphA5 expression and promoter methylation in the retina
To determine whether there are developmental (age-related) or spatial (nasal vs. temporal; dorsal vs. ventral) differences in CpG methylation of EphA5, we analyzed CpG island (À243 to +242 bp relative to TSS) by bisulfite sequencing of genomic DNA from the mouse retina and compared this to differences in mRNA expression. By quantitative RT-PCR, there was a small, but progressive decline in EphA5 mRNA expression with age (Fig. 3A) . Relative to E17.5, EphA5 expression was unchanged at post-natal day 0 (P0) and decreased by 26% at 8 months (p = 0.05). Despite the decrease in EphA5 mRNA expression, CpG methylation of EphA5 was unchanged. Overall methylation was 1.2 ± 0.3% at E17.5, 1.6 ± 0.5% at P0, 1.2 ± 0.3% for PM8 (Fig. 3B ) with no statistically significant differences.
Dissection of retina into thirds at P0 revealed that the distribution of cells showing methylation of the EphA5 promoter in the retina was highly unequal. For dorso-ventrally dissected retina, of which only the dorsal and the ventral thirds were analyzed, the total methylation level detected was below 1% in both the dorsal and ventral retina (Fig. 4C ). There were no differences in methylation levels between the two domains (p = 0.32 dorsal vs. ventral). In contrast, for nasal-temporally dissected retina, of which only the nasal and the temporal thirds were analyzed, the overall methylation level was higher (Fig. 4C ). This indicates that methylated cells were preferentially localized to the median third of the retina, as opposed to the dorsal/ventral domains and, within this third, methylation frequency was highest in the nasal portion (p = 0.01 vs. temporal). Significant up-regulation of EphA5 mRNA expression was observed only in the temporal third of nasal-temporally 
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Graphs showing mean relative EphA5 mRNA expression in dorsal and ventral thirds of the mouse retina at P0 determined using qRT-PCR and normalized to dorsal retina. EphA5 mRNA expression was 1.15 ± 0.0-fold higher in the ventral vs. dorsal retina (p = 0.32). For both A and B, three biological replicates were analyzed, with each sample analyzed in triplicate. Error bars = standard error of the mean. (C) Methylation frequency of EphA5 CpG island shown in bubble diagrams for nasal, temporal, dorsal and ventral thirds of mouse retina at P0. Each line represent a clone, circles show CpG dinucleotides. Open circles = unmethylated, black circles = methylated. The EphA5 CpG island spanning the transcription start site (485 bp) was amplified from bisulfite converted gDNA in a nested PCR. EphA5 CpG methylation at P0 varied topographically. The highest CpG methylation was in the nasal retina (3.29 ± 0.84%), compared to temporal (1.5 ± 0.46%; p = 0.01 vs. nasal). Dorsal retina (0.63 ± 0.21%) and ventral retina (0.28 ± 0.7%) had minimal methylation and differences between dorsal and ventral were not statistically significant (p = 0.32). Numbers at the bottom show the position of the CpG island in base pairs relative to the transcription start site (TSS, arrow). dissected retina (Fig. 4A) , while there were no significant difference in EphA5 mRNA expression between the dorsal or ventral thirds (Fig. 4B) .
Effects of methylation of EphA5 promoter
To assess the effects of methylation on promoter activity, the EphA5 promoter (À1552 to +997 bp) was subcloned into a CpG free luciferase vector, pCpGL and methylated by SssI methyltransferase. SssI methylates 98 CpG sites within the EphA5 promoter and reduced activity of the pCpGL-EphA5 construct by 92% (p < 0.0001) (Fig. 5) . Because total methylation is well known to silence gene expression and we had only observed low levels of EphA5 promoter methylation in the retina, we tested whether lower levels of CpG methylation could also silence the EphA5 promoter. The pCpGLEphA5 construct was methylated with HhaI methyltransferase, which methylates 10 CpG sites (CGCG) and/or HpaII methyltransferase, which methylates six CpG sites (CCGG) within the EphA5 promoter (Fig. 5) . When compared to mock methylated construct, HhaI decreased promoter activity by 20% (p = 0.032). Surprisingly, HpaII methylation resulted in a 35% increase (p = 0.008) of EphA5 promoter activity and constructs methylated with both HhaI and HpaII methyltransferases continued to show increased activity (38%, p = 0.002 vs. mock-methylated control). Thus, whereas the EphA5 promoter was completely silenced by total methylation of all CpG dinucleotides, introducing low levels of site-specific CpG methylation in the EphA5 construct could elicit either increased or decreased promoter activity, depending on the methylated sites.
mRNA expression and methylation of EphA5 and EphB2 in ImM10 Müller glia
Our lab has been investigating the neurogenic potential of Müller glia and have generated a conditionally immortalized mouse Müller glia cell line (ImM10) (Otteson & Phillips, 2010) that can generate spheres similar to neurospheres following EGF/FGF2 stimulation (Fig. 6A) . For ImM10 cells and other Müller glia to be useful as potential sources of retinal stem cells for regeneration, they need to retain the ability to up-regulate and express genes necessary for neuronal differentiation. First, we asked if ImM10 cells expressed Eph receptors. By qRT-PCR, EphA5 receptor is weakly expressed (average Ct value, 38 cycles) in ImM10 cells, but was undetectable in sphere cultures (Fig. 6B) . Bisulfite sequencing showed hypermethylation of the EphA5 promoter methylation in ImM10 under immortalizing conditions (49.6%) and sphere cultures under non-immortalizing conditions (47.8%) (Fig. 6E) . The difference in methylation between the two culture conditions was not statistically significant (p = 0.5805). To determine whether increased DNA methylation and transcriptional silencing were general characteristics of all Eph receptor genes in ImM10 cells, we also analyzed expression and methylation of EphB2. EphB2 was expressed in ImM10 cells in both growth and sphere cultures and was unmethylated (Fig. 6F) .
Effects of demethylation of ImM10 cells using AzadC
If DNA methylation is repressing EphA5 in ImM10 cells, then demethylation should permit up-regulation of expression. We tested multiple concentrations of AzadC for cytotoxicity in ImM10 cells using MTT assays and found minimal effects up to 100 lM (Supplementary Fig. S1 ). We then tested the efficacy of AzadC demethylation of H19, a paternally imprinted gene that is known to be demethylated by AzadC treatment (El Kharroubi, Piras, & Stewart, 2001) . By bisulfite sequencing, 1 or 10 lM AzadC treatment resulted in a systematic and statistically significant demethylation of H19 (Supplementary Fig. S2 ), therefore, we used these concentrations for our analysis. Sphere cultures of ImM10 cells treated with AzadC showed a significant decrease in DNA methylation of 25.4 ± 2.9% (1 lM, p = 0.01) or 24.5 ± 6.1% (10 lM, p = 0.001) (Fig. 6E) and an up-regulation of EphA5 mRNA expression by 99.2 ± 6.1 or 94.6 ± 11.2-fold, respectively compared to untreated controls (Fig. 6B and C) . Following AzadC treatment, no obvious changes in cell morphology or in the size of the spheres were observed. Spheres remained non-adherent with no migration of cells out of the spheres during the 72 h treatment period. To look for possible non-specific effects of AzadC treatment on gene expression, we also analyzed methylation and expression of EphB2 and found that AzadC treatment had no effect on methylation levels or expression of EphB2 (Fig. 6B, D, F) .
Discussion
We report here the cloning of the mouse EphA5 promoter and provide evidence for a potential role for DNA methylation in modulating EphA5 gene expression in the retina in vivo and a clear role for DNA methylation in silencing EphA5 expression in ImM10 Mül-ler glia in vitro. Global genome-wide DNA methylation changes with age with a tendency towards hypermethylation in many genes (Gravina & Vijg, 2010) . However, we did not detect any changes in overall DNA methylation in genomic DNA from whole retinas even at 8 months of age. In contrast, there were topographic differences at P0, prior to refinement and pruning of axon terminals and the wave of programmed cell death of RGCs (Farah & Easter, 2005; O'Leary & McLaughlin, 2005) . However, there was a modest increase in methylation the nasal retina in CpG sites immediately downstream of the transcription start site. The increased methylation corresponded to decreased mRNA expression in the nasal retina suggesting a potential regulatory role for methylation in modulating EphA5 expression. Total DNA methylation results in chromatin compaction, blocking transcription factor binding and recruitment of methyl binding proteins which assist in the deacetylation of histones, although reports regarding the precise hierarchy of events during chromatin remodeling are contradictory (Vaissiere, Sawan, & Herceg, 2008) . In contrast, site-specific methylation can alter binding affinities of specific transcription factors which can differentially activate or repress transcription (Cao, Jean, & Williams, 2000) . Consistent with this, we showed that although methylation of all CpG sites resulted in silencing of EphA5 promoter activity, lower levels of methylation resulted in differential activation or repression of EphA5 promoter activity, depending on the sites methylated. The observation that promoter repression by HpaII methylation could not overcome promoter activation by HhaI methylation suggests that inactivation of potential repressor elements in the promoter through DNA methylation is likely to exert stronger control on transcription than loss of positive regulatory elements.
Most of the proposed transcriptional regulators of EphA5, including HMX1, FOXD1 and FOXG1, bind to AT rich sites that lack CpG dinucleotides (Amendt, Sutherland, & Russo, 1999; Obendorf et al., 2007; Zhang et al., 2003) and are therefore unlikely to be directly affected by methylation of their consensus binding sites. Zic2 binds to a GC-rich consensus site and has been implicated as a regulator of EphB1 (Herrera et al., 2003) . Although the identity of other regulatory targets for ZIC2 in the retina remains undetermined, we have identified several potential ZIC2 binding sites in the EphA5 promoter. Interestingly, ZIC2 can displace SP1 and SP3 at consensus binding sites in D(1A) dopamine receptor promoter to block Sp1-mediated transactivation (Yang, Hwang, Junn, Lee, & Mouradian, 2000) . Sp1 and Sp3 are members of the larger Sp/Klf family of transcription factors that can recognize similar CG rich consensus sites and either activate or repress transcription, depending on the promoter context (Kaczynski, Cook, & Urrutia, 2003) . There are multiple predicted binding sites for Sp/Klf factors in the EphA5 promoter and SP1/SP3 sites coincide with seven of the HhaI sites and four of the HpaII methylation sites (Supplementary Table S2 ). DNA methylation has variable effects on SP1 binding and in some genes, methylation in flanking sequences can decrease SP1/SP3 binding (Zhu et al., 2003) . Interestingly, T 1a, a gene expressed in lung but not in brain, can be silenced in the brain by methylation of a single SP1/3 binding site (Cao et al., 2000) . Fourteen of the seventeen Klf transcription factors are expressed in RGCs at E18 and P0 and over-expression of specific Klf cDNAs in RGCs differentially promotes axon outgrowth or retraction (Moore et al., 2009 ). Thus, methylation of GC-rich consensus binding sites, potentially for ZIC2 or SP/KLF transcription factors, could alter binding affinity of transcription factors for specific sites, resulting in modulation EphA5 promoter activation or repression.
We used genomic DNA and RNA isolated from whole retinas for our analyses. Therefore, although we saw subsets of clones with potentially interesting patterns of methylation, attributing a particular methylation pattern to a specific cell type within the retina is not possible. However, we can draw some inferences based on the populations present at the time points analyzed. Since progenitor cells constitute a large fraction of all cells present in the E17.5 and P0 retinas, we infer that EphA5 is largely unmethylated in both early and late-stage retinal progenitors. At 8 months, rod photoreceptors are the single most abundant cell types in the retina, thus, we infer that EphA5 remains unmethylated in rod photoreceptors. However, in the mature mouse retina, Müller glia and RGC respectively constitute $3% and <1.3% of all retinal cells (Jeon, Strettoi, & Masland, 1998) . Thus, even with a sampling depth of 20 clones, we would expect, on average, that less than one clone would represent genomic DNA from Müller glia or retinal ganglion cells. Therefore, the patterns of DNA methylation and the potential role for methylation in regulating EphA5 expression specifically in RGCs or Müller cells in vivo will require analysis of pure cell populations.
There is evidence supporting a role for DNA methylation in disregulation of EphA5 and expression of other Eph receptor in cancer (Dottori et al., 1999; Fu et al., 2010; Kalinski et al., 2009; Kuang et al., 2010; Merlos-Suarez & Batlle, 2008; Wang et al., 2005) . Decreased EPHA5 mRNA expression is associated with increased promoter methylation in human primary breast cancer (Fu et al., 2010) . In cancer cells, AzadC can reverse DNA hypermethylation and re-establish patterns of gene expression typical of non-cancerous cells (Bird, 2002) . Our results showing decreased methylation and up-regulation of EphA5 in ImM10-derived sphere cultures following AzadC treatment are consistent with the up-regulation of EphA5 following AzadC demethylation in mammary tumor cell lines (Fu et al., 2010) . Our results support a role for DNA methylation in silencing EphA5 and suggest a potential mechanism for silencing other developmentally important genes in Müller gliaderived spheres.
Methylation analysis of freshly isolated and cultured cells has shown that global methylation patterns are maintained in longterm cultures, although there are changes in specific CpG sites, particularly in genes involved in differentiation (Bork et al., 2010) . SV40 transformed cell lines are known to have increased levels of DNA methylation (Liu et al., 2005) . The conditional immortalization of Müller glia with the tsA58-SV40 transgene (Jat et al., 1991) could contribute to the increased methylation of EphA5 in ImM10 cells. However, increased methylation in this cell line is clearly gene specific, as EphB2 was found to be essentially unmethylated in ImM10 cells under both immortalizing and non-immortalizing (sphere forming) conditions. It will be important to determine whether silencing of EphA5 by methylation is a general characteristic of Müller glia, both in vitro and in vivo, and whether other developmentally critical genes are also silenced by DNA methylation in Müller glia.
Müller glia have been proposed as a possible source of stem-like cells that could be used for regenerative strategies in the retina (Jadhav, Roesch, & Cepko, 2009; Karl et al., 2008) . During retinal development, Müller glia are generated from late-stage progenitors and both cell types express many of the same genes (Blackshaw et al., 2004; Otteson & Phillips, 2010; Roesch et al., 2008 ), yet their ability to de-differentiate and generate retinal neurons remains limited at best, both in vivo and in vitro (Karl et al., 2008; Lawrence et al., 2007) . Removal of epigenetic marks, including DNA and histone methylation, induces re-expression of pluripotency-associated genes in somatic cells (Bian, Alberio, Allegrucci, Campbell, & Johnson, 2009; Miyamoto et al., 2009) and in brain-derived neurospheres (Ruau et al., 2008) . Our results point to a possible role for chromatin remodeling in silencing of developmentally important genes in Müller glia. Although we did not observe any morphological changes in the EGF/FGF2 induced sphere cultures following demethylation, this is not entirely unexpected given the short time-course of the treatment and the fact that we did not switch the cells to differentiation media that can induce up-regulation of some neuronal genes in vitro. It will be interesting to determine which other neuronal genes are silenced by methylation in Müller glia and whether hypermethylation is a general characteristic of all Müller glial cell lines and of primary Müller glia. The finding that demethylation promotes re-expression of EphA5 in ImM10 cells suggests that AzadC treatment may be a useful approach for increasing the neurogenic potential of Müller glia in vitro and in vivo.
